Clinical Trials Sponsored by AI-Robotics Technology Co., Ltd

Total 778 results

National Vaccine and Serum Institute, China
Guangxi Center for Disease Control and Prevention; Simoon Record Pharma Information... and other collaborators

Completed

Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)

HPV Infection | HPV-Related Cervical Carcinoma

China
National Vaccine and Serum Institute, China
Guangxi Center for Disease Control and Prevention; Simoon Record Pharma Information... and other collaborators

Completed

A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

HPV Infection | HPV-Related Cervical Carcinoma

China
National Vaccine and Serum Institute, China
Zhengzhou University; Lanzhou Institute of Biological Products Co., Ltd; Beijing...

Recruiting

Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha)

Norwalk Gastroenteritis | Norovirus Infections

China
National Vaccine and Serum Institute, China
Zhengzhou University; Lanzhou Institute of Biological Products Co., Ltd; Beijing...

Completed

A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine

Norwalk Gastroenteritis | Norovirus Infections

China
Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd...
The First Affiliated Hospital of Guangzhou Medical University

Not yet recruiting

Study of Human Bone Marrow Mesenchymal Stem Cells in aPAP

Autoimmune Pulmonary Alveolar Proteinosis
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Recruiting

A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.

Leukemia, B-cell

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Relapse | CD19 Positive | Refractory

China
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Unknown

CAR-T for R/R B-NHL

Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | CAR - T CD19/CD20/CD22/CD30

China
Sichuan J.Z. Bio-chemical Science and Technology...
Peking University Cancer Hospital & Institute

Completed

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Advanced Cancer

China
Shenzhen Zhongke Jingcheng Medical Technology Co...
Chinese University of Hong Kong; Shenzhen Institute of Advanced Technology,...

Recruiting

Mg-containing Biodegradable Polymer Bone Repair Material

Bone Deformity

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer

Prostate Cancer

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment

Acute Lymphoblastic Leukemia in Remission

China
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Recruiting

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

Acute Lymphoblastic Leukemia With Failed Remission

China
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Unknown

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma

China
Beijing Jishuitan Hospital
Chinese PLA General Hospital; Tianjin Hospital; Beijing Tinavi Medical Technology...

Completed

Clinical Trial for the Application of Tirobot System

Robotic Surgical Procedures | Fusion of Spine (Disease)

China
Nanjing NingQi Medicine Science and Technology...
Jiangsu Province Hospital of Traditional Chinese Medicine

Unknown

Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients

Colon Cancer

China
Shenzhen Beike Bio-Technology Co., Ltd.
Shandong Jiaotong Hospital; Association for the Handicapped Of Jinan

Completed

Safety and Efficacy of Stem Cell Therapy in Patients With Autism

Autism

China
The First Affiliated Hospital of Soochow University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Recruiting

Anti-BCMA CAR T-Cell Therapy for R/R ITP

ITP

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia

Relapsed or Refractory Acute Lymphoblastic Leukemia

China
Shanghai Unicar-Therapy Bio-medicine Technology...
The First Affiliated Hospital of Soochow University

Recruiting

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

B-cell Acute Lymphocytic Leukemia

China
Dongzhimen Hospital, Beijing
Beijing Union pharmaceutical factory II; Beijing Compete Medical Technology...

Completed

Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia

Vascular Dementia

China
First Affiliated Hospital of Harbin Medical University
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Unknown

Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.

Pancreatic Cancer | CAR

China
Beijing 302 Hospital
Beijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of...

Not yet recruiting

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma
Institute of Hematology & Blood Diseases Hospital
Shanghai Cell Therapy Engineering Technology Research Center Group Co., Ltd.

Unknown

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Transformed Lymphoma

China
Inuling (Bei Jing) Science and Technology Co. Ltd
Peking Union Medical College Hospital; Proswell Medical Corporation

Completed

Effect of Inulin-type Fructose Extracted From Jerusalem Artichoke on Improving Prediabetic State of Type 2 Diabetes

Prediabetes
Xiamen University
Ministry of Science and Technology of the People´s Republic of China; Xiamen... and other collaborators

Completed

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Cervical Cancer | Cervical Intraepithelial Neoplasia | Vaginal Intraepithelial Neoplasia | Vulvar Intraepithelial Neoplasia | Persistent Infection

China
Beijing 302 Hospital
Beijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of...

Not yet recruiting

Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody

Hepatocellular Carcinoma
Shenzhen Raysight Intelligent Medical Technology...
Shanghai Zhongshan Hospital; West China Hospital; Shenzhen People's Hospital

Not yet recruiting

Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Vascular Disease Occlusive

China
Neuracle Medical Technology(Shanghai) Co.,Ltd.
Beijing Tiantan Hospital; Chinese PLA General Hospital; Xuanwu Hospital, Beijing

Not yet recruiting

Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability

Tetraplegia

China
Nuwacell Biotechnologies Co., Ltd.
The First Affiliated Hospital of University of Science and Technology of...

Not yet recruiting

A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes

Relapsed / Refractory Myelodysplastic Syndromes
Shanghai Keku Medical Technology Co., Ltd.
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Not yet recruiting

A Randomized, Double-blind, Controlled Study to Evaluate the Safety and Feasibility of a Intraoral Electrotherapy Device

Periodontal Diseases
Qidong Gaitianli Medicines Co., Ltd
Huazhong University of Science and Technology; Second Hospital of Jilin University

Active, not recruiting

Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery

Gastrointestinal Cancer

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou Anjie Biomedical Technology Co., Ltd.

Completed

PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer

Advanced Breast Cancer | Breast Neoplasm Malignant Female

China
Sichuan J.Z. Bio-chemical Science and Technology...
Beijing Shijitan Hospital, Capital Medical University

Completed

Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma

Glioblastoma

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
The First Affiliated Hospital of Nanchang University; Chinese PLA General Hospital and other collaborators

Not yet recruiting

Evaluate the Safety and Effectiveness of the Endoscopic Surgical Instrument Control System (SP1000).

Urologic Neoplasms

China
Sixth Affiliated Hospital, Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.; Nanjing Geneseeq Technology Inc.

Recruiting

Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer

Advanced Esophageal Cancer

China
Zhujiang Hospital
Guangdong Xiangxue Precision Medical Technology Co., Ltd.; Xiangxue Life Science... and other collaborators

Completed

To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors

Solid Tumor | Breast Cancer Stage IV | Gastric Cancer Stage IV | Ovarian Cancer Stage IV | Liver Cancer Stage IV | Esophageal Cancer, Stage IV | Bone and Soft Tissue Tumors | Bladder Carcinoma Stage IV | Prostate Carcinoma Stage IV | Thyroid Cancer Stage IV

China
Sinovac Biotech Co., Ltd
Ministry of Science and Technology of the People´s Republic of China

Completed

Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects

Influenza

China
Tongji Hospital
Gelesis, Inc.; Geneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver... and other collaborators

Recruiting

Primary Hepatobiliary Cancer Cohort of Central China (CCGLC-002)

Hepatocellular Carcinoma | Biliary Tract Neoplasms

China
Beijing Friendship Hospital
Beijing Ditan Hospital; Nanfang Hospital of Southern Medical University; Ruijin... and other collaborators

Active, not recruiting

Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients

Chronic Hepatitis b

China
Wan-Guang Zhang
BeiGene; Geneplus-Beijing Co. Ltd.; Simcere Pharmaceutical Co., Ltd; Chinese Cooperative... and other collaborators

Recruiting

Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC (CCGLC-007)

Hepatocellular Carcinoma

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Sichuan Center for Disease Control and Prevention; Neijiang Center for Disease... and other collaborators

Completed

Phase I Clinical Protocol of BCG-PPD in Healthy People

Tuberculosis

China
Shanghai Yinnuo Pharmaceutical Technology Co.,...
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...

Completed

A Study of the Efficacy and Safety of Supaglutide in Healthy Participants

Diabetes Mellitus, Type 2

China
Changchun Changsheng Life Science and Technology...
Guangdong Provincial Institute of Biological Products And Materia Medica

Unknown

Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children

Chickenpox

China
The First Affiliated Hospital with Nanjing Medical...
Innovent Biologics (Suzhou) Co. Ltd.; Nanjing Geneseeq Technology Inc.

Not yet recruiting

A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.

Gastric Cancer
Boston Intelligent Medical Research Center, Shenzhen...
Zhongshan Hospital Of Traditional Chinese Medicine

Recruiting

Different Administration Routes of Dexmedetomidine on Postoperative Delirium

Postoperative Delirium | General Anesthesia | Dexmedetomidine

China
China Agricultural University
General Hospital of Chinese Armed Police Forces; Beijing Anzhen Hospital; Peking... and other collaborators

Completed

Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)

Kidney Failure, Chronic

China
Changchun BCHT Biotechnology Co.
The First Affiliated Hospital of Yunnan University of Traditional Chinese... and other collaborators

Not yet recruiting

Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1

Rabies Virus Infection

China
New Discovery LLC
NYU Langone Health; Stanford University; Baylor University; Rush University; Wuxi...

Recruiting

Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US

Fatty Liver | Liver Fibrosis

United States

Clinical Trials Sponsored by AI-Robotics Technology Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations